SEEN, a haircare brand developed by Harvard-trained Dermatologist Dr. Iris Rubin, has closed a $9 million Series A funding. This funding will accelerate SEEN’s growth as the premier science-backed, clinically proven beauty brand. The participants include Mitch Rales, Co-Founder of Danaher Corporation; Somerville SPV, led by acclaimed investor Feroz Dewan; Sator Grove Holdings, a permanent capital investor; and George Mrkonic, a Board Director of Ulta Beauty. SEEN also received early funding support from renowned Harvard dermatologists and scientists, including Dr. Rox Anderson at Harvard/Massachusetts General Hospital.
By pioneering the skinification of hair care, SEEN is bridging the gap between luxury haircare and skincare. And the brand’s success stems from Dr. Rubin’s groundbreaking insight that hair products can clog pores and irritate the skin, causing acne, eczema, and other issues. After struggling for years with breakouts, Dr. Rubin identified her haircare products as the cause. Following four years of development, SEEN launched in 2019 with three core hair products and has since grown into a complete line of haircare and styling products.
SEEN applies rigorous skin science and testing to its formulations. And SEEN’s Epidermal Rebalancing Technology uses efficacious skin-friendly ingredients to develop hair and body products that deliver stronger, smoother, healthier hair and healthy-looking skin. SEEN has received five patents, over 7,000 5-star reviews, and over a dozen beauty awards, and holds the National Eczema Association’s Seal of Acceptance for its fragrance-free line.
KEY QUOTES:
“This marks another transformative milestone for SEEN. A majority of adults in the U.S. have self-described sensitive skin and over 100 million people in the U.S. suffer from acne, eczema, dry scalp, and hair shedding, which can be exacerbated by irritating, allergenic, and/or pore-clogging ingredients in hair products. Our mission is to help people feel confident being seen by providing them salon-quality hair formulations clinically proven to also be skin friendly.”
-Dr. Iris Rubin, Co-Founder of SEEN
“Our Series A funding will allow us to focus on innovation, further scale our professional sampling to 10,000 dermatology practices in 2025, and expand our retail footprint. We’ve had 100% compounded annual growth since our launch and consistently exceed Ulta’s sales projections for the brand.”
-Greg Maged, Co-Founder of SEEN
“I am delighted to become an investor in SEEN and believe they are setting a new standard for performance hair care. SEEN is applying skin science to haircare, which is exactly the kind of category-defining innovation that gets Ulta excited.”
-Investor George Mrkonic, who currently serves on the Board of Ulta Beauty
“When we invest in a brand, we look for companies with large market potential, strong margins, and a platform that creates unique consumer benefits. We also want to invest in leadership that is smart, agile, and driven by a passion for excellence. SEEN embodies all these qualities.”
-Mitch Rales, SEEN investor
